MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹90 Cr | ₹44 Cr | ₹37 Cr | ₹35 Cr | ₹30 Cr |
What is the latest Total Non-Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹35 Cr |
| Mar2021 | ₹30 Cr |
How is Total Non-Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹90 Cr | 105.96 | |
| Mar2024 | ₹44 Cr | 19.11 | |
| Mar2023 | ₹37 Cr | 3.91 | |
| Mar2022 | ₹35 Cr | 18.10 | |
| Mar2021 | ₹30 Cr | - | |
Compare Total Non-Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹1,949.8 Cr | -7.7% | -8.2% | -44.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -7.7% |
-8.2% |
-44.7% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses